Johnson & Johnson’s pharmaceutical arm, Janssen, embarked on a global effort to combat the COVID-19 pandemic. To support their goal of supplying one billion doses of vaccine, an agreement with a contract manufacturer was reached. Large-scale manufacturing of Janssen’s vaccine would take place at the contract manufacturing site, which is designed for rapid manufacturing of vaccines and other treatments in large quantities during public health emergencies.
Baltimore Biotech Earns International Recognition forAdvanced Development and Manufacturing Facility
Baltimore Biotech Earns International Recognition for Advanced Development and Manufacturing Facility December 19, 2018 Located in Eastern Baltimore, just off of I-95 is Emergent BioSolutions’ Center for Innovation in Advanced [….]